oral semaglutide novo nordisk Novo Nordisk to protect US patients from unlawful sales of non-FDA approved 'semaglutide medicines' The Ozempic Pill Has Arrived.

declared the beginning of a 500,000-ton Acetate and 100,000-ton electronic grade ethyl acetate project in Jingmen to expand its industrial chain and meet the huge demand of acetates in wider applications

Phase 3 trials swapped out the 8 mg dose for 6 mg and 9 mg doses based on the phase 2 data

Cholecystectomy alters bile release patterns and gut hormone signaling, which can affect both GLP-1 tolerability and weight loss response

Massachusetts is among a minority of states where Medicaid pays for GLP-1s to treat obesity without requiring that patients also suffer from other weight-related conditions

Journal reference: Budini, B., Luo, S., Tam, M., et al

doi: 10.1038/s41577-022-00792-3 20